欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Celdoxome pegylated liposomal	Human	doxorubicin hydrochloride	doxorubicin hydrochloride	EMEA/H/C/005330	Baxter Holding B.V.	2022/09/15	Authorised
Zolsketil pegylated liposomal	Human	doxorubicin	doxorubicin hydrochloride, liposomal	EMEA/H/C/005320	Accord Healthcare S.L.U.	2022/05/31	Authorised
Myocet liposomal (previously Myocet)	Human	doxorubicin	doxorubicin hydrochloride	EMEA/H/C/000297	CHEPLAPHARM Arzneimittel GmbH	2000/07/13	Authorised
Caelyx pegylated liposomal	Human	doxorubicin	doxorubicin hydrochloride	EMEA/H/C/000089	Baxter Holding B.V.	1996/06/20	Authorised
Doxorubicin Hydrochloride Tillomed	Human	doxorubicin	doxorubicin hydrochloride	EMEA/H/C/005194	Laboratorios Tillomed Spain S.L.U		Application withdrawn
Doxolipad	Human	doxorubicin	doxorubicin hydrochloride	EMEA/H/C/004110	TLC Biopharmaceuticals B.V.		Refused
Doxorubicin SUN	Human	doxorubicin	doxorubicin hydrochloride	EMEA/H/C/002049	Sun Pharmaceutical Industries Europe B.V.		Application withdrawn

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-